Therapeutic drug monitoring in psychiatry - Reference ranges for the dose-concentration-relationship;Therapeutisches drug-monitoring in der psychiatrie - Erstellung von referenzbereichen für die dosis-konzentrations-beziehung

Psychiatrische Praxis, Supplement

Volumn 34, Issue 1, 2007, Pages

  Greiner, Christine ^a,b   Haen, Ekkehard ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Antipsychiotics; Dose concentration relationship; Reference ranges; TDM; Therapeutic drug monitoring

Indexed keywords

LAMOTRIGINE;

CONCENTRATION RESPONSE; CONFERENCE PAPER; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG MONITORING; DRUG USE; HUMAN; METHODOLOGY;

EID: 33847767907     PISSN: 16118332     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-940201     Document Type: Conference Paper

References (5)

1. Haen E. Bedeutung der klinisch-pharmakologischen Befundung von Wirkstoffkonzentrationsmessungen zur Therapieleitung. Psychopharmakotherapie 2005; 4: 138-143
2. Baumann P et al. The AGNP-TDM Expert group consensus guideline: Therapeutic drug monitoring in psychiatry. Pharmacopsychiatry 2004; 37: 243-265
3. Chan V et al. Population Pharmacokinetics of Lamotrigine. Therapeutic Drug Monitoring 2001; 23: 630-635
4. Kanner AM, Frey M. Adding valproate to lamotrigine: a study of their pharmacokinetic interaction. Neurology 2000; 55: 588-591
5. May TW et al. Serum concentrations of lamotrigine in epileptic patients: the influence of dose and comedication. Ther Drug Monit 1996; 18: 523-531